Sartorius Stedim Biotech S.A.
SDMHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,220,608 | $19,700,916 | $18,341,100 | $18,325,575 |
| - Cash | $350,507 | $699,300 | $707,600 | $678,900 |
| + Debt | $3,007,527 | $2,969,300 | $2,932,800 | $2,869,600 |
| Enterprise Value | $21,877,628 | $21,970,916 | $20,566,300 | $20,516,275 |
| Revenue | $828,097 | $745,000 | $744,600 | $751,300 |
| % Growth | 11.2% | 0.1% | -0.9% | – |
| Gross Profit | $384,184 | $344,700 | $356,300 | $316,300 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| EBITDA | $255,458 | $201,400 | $256,100 | $132,700 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |
| Net Income | $75,335 | $68,500 | $85,600 | $45,600 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS Diluted | 0.77 | 0.69 | 0.88 | 0.47 |
| % Growth | 11.6% | -21.6% | 87.2% | – |
| Operating Cash Flow | $70,876 | $124,900 | $119,800 | $284,900 |
| Capital Expenditures | -$158,297 | -$75,900 | -$65,300 | -$80,000 |
| Free Cash Flow | -$87,421 | $49,000 | $54,500 | $204,900 |